Article
ADAMTS13 and TTP.
Current opinion in hematology - 1 Sept 2002
Zheng Xinglong, Majerus Elaine M, Sadler J Evan
Abstract excerpt
Thrombotic thrombocytopenic purpura (TTP) has been a mysterious and deadly disease that often could be treated effectively by plasma exchange, but without real understanding of the underlying pathophysiology. Recent advances now suggest that deficiency of a specific von Willebrand factor (VWF) cleaving protease promotes tissue injury in TTP. VWF multimers participate in the formation of platelet thrombi....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
